Retraction: Chamaejasmin B decreases malignant characteristics of mouse melanoma B16F0 and B16F10 cells - Scorecard - MDSpire

Retraction: Chamaejasmin B decreases malignant characteristics of mouse melanoma B16F0 and B16F10 cells

  • April 30, 2026

  • 0 min

Share

Clinical Scorecard: Withdrawal of Study: Chamaejasmin B Reduces Malignant Traits in Mouse Melanoma B16F0 and B16F10 Cell Lines

At a Glance

CategoryDetail
Condition
Key MechanismsChamaejasmin B's effects on malignant characteristics, including tumor growth and behavior.
Target Population
Care Setting

Key Highlights

  • Investigation confirmed breaches of ethical guidelines and misrepresentation of findings.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Not applicable (animal study)

          Not applicable (study retracted)

          Clinical Best Practices

          • Conduct thorough ethical review prior to experiments to ensure compliance with animal welfare standards.

          References

          Original Source(s)

          Related Content